In the rapidly evolving field of pharmaceutical development, particularly in targeted drug delivery, the precise selection of excipients is paramount. Phospholipids, such as 1,2-Di(cis-13-docosenoyl)-sn-glycero-3-phosphoethanolamine (PE 22:1/22:1), play a pivotal role in the formulation of advanced delivery systems like liposomes and micelles. These structures are instrumental in encapsulating therapeutic agents, protecting them from degradation, and facilitating their targeted release within the body.

The unique amphipathic nature of PE(22:1/22:1) allows it to self-assemble into stable bilayer structures. This property is fundamental for creating liposomes, which are essentially spherical vesicles composed of lipid bilayers enclosing an aqueous core. Researchers frequently seek out high-purity phospholipids from reliable manufacturers to ensure the integrity and efficacy of their liposomal formulations. As a leading biochemical supplier in China, NINGBO INNO PHARMCHEM offers premium grade PE(22:1/22:1), enabling scientists to buy with confidence for their critical research and development projects.

The long, unsaturated acyl chains (cis-13-docosenoyl) in PE(22:1/22:1) contribute to the fluidity and flexibility of the resulting lipid bilayers. This characteristic is crucial for understanding lipid dynamics and can influence the interaction of the delivery system with biological membranes and tissues. Furthermore, PE(22:1/22:1) can be modified or combined with other lipids to tailor the physicochemical properties of the formulation, optimizing factors such as stability, drug encapsulation efficiency, and release kinetics.

For procurement specialists and R&D scientists looking to buy this essential component, partnering with a knowledgeable manufacturer and supplier is key. NINGBO INNO PHARMCHEM is dedicated to providing high-quality biochemicals, including PE(22:1/22:1), to support innovations in pharmaceutical science. We ensure a consistent supply and competitive pricing, making us an ideal partner for your ongoing research needs.